ArticlemedRxiv : the preprint server for health sciences2025
Longitudinal study of gesture decoding in a clinical trial participant with ALS.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03567213 (Investigation on the Cortical Communication), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Investigation on the Cortical Communication (CortiCom) System
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Brain-computer interfaces (BCIs) have the potential to preserve or restore communication and device control in people with paralysis from a variety of causes. For people living with amyotrophic lateral sclerosis (ALS), however, the progressive loss of cortical motor neurons could theoretically pose a challenge to the stability of BCI performance. Here we tested the stability of gesture decoding with a chronic electrocorticographic (ECoG) BCI in a man living with ALS and participating in a clinical trial (ClinicalTrials.gov, NCT03567213). We evaluated offline decoding performance of attempted gestures over two periods: a 5-week period beginning roughly 2 years post-implant and a 6-week period ending roughly 5 months later. Decoder sensitivity was high in both periods (90 - 98%), while classification accuracy was 37 - 68% in the first period and worsened to 23 - 39% in the second. We investigated multiple frequency bands that were used as model features in both periods, and we observed reductions in high gamma band power (70 - 110 Hz) and between-class separation during the second period compared to the first. Over the 5-month period motor function did not appreciably decline. These results, albeit preliminary, suggest that declines in the neural population responses that drive ECoG BCI performance can occur without overt signs of disease progression in people living with ALS, and could serve as a biomarker for disease progression in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.